Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease adenocarcinoma of esophagus
Comorbidity C0004763|barrett\'s oesophagus
Sentences 6
PubMedID- 24221456 Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with barrett's oesophagus: a systematic review and meta-analysis.
PubMedID- 25633286 Nsaids, statins, low-dose aspirin and ppis, and the risk of oesophageal adenocarcinoma among patients with barrett's oesophagus: a population-based case-control study.
PubMedID- 21143918 There are few clear prognostic indicators of susceptibility to developing oesophageal adenocarcinoma although patients with barrett's oesophagus are thought to be more at risk to developing oesophageal adenocarcinoma.
PubMedID- 20550712 The 'exercise and the prevention of oesophageal cancer study' will determine whether 24 weeks of exercise training will lead to alterations in risk factors or biomarkers for oesophageal adenocarcinoma in males with barrett's oesophagus.
PubMedID- 22353776 Observational data have also indicated that statins may have protective effects against the development of cancer, for example, modifying the risk of oesophageal adenocarcinoma in patients with existing barrett's oesophagus [20].
PubMedID- 26311716 Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with barrett's oesophagus.

Page: 1